溶瘤病毒在犬肿瘤治疗中的研究进展

doi:10.16431/j.cnki.1671-7236.2020.03.037

Abstract

Abstract: Oncolytic virotherapy is a promising new biological therapy for the treatment of malignant tumors using viruses.The oncolytic virus not only directly infects and dissolves tumor cells,but also stimulates the immune response at the tumor site,to indirectly dissolve the tumor tissue cells,and has no killing or wake killing effect on normal tissue cells,thus achieving satisfying anti-tumor effect.In this paper,the development history of oncolytic virus and the mechanism of tumor ablation mediated by oncolytic virus were reviewed.Then we analyzed the killing effect on various canine tumor cells in vitro,in xenotransplantation tumor animal model and in dogs with tumor of eight oncolytic viruses including measles virus,canine distemper virus,Newcastle disease virus and Sendai virus and so on.Some encouraging results suggested that oncolytic virotherapy might become a safe and reliable new method for the treatment of malignant tumors.However,in order to apply oncolytic virotherapy in the clinical treatment of canine tumors,many problems still need to be solved,such as how to ensure the specificity of the virus,and how to determine the dose of the virus.In summary,this article provided new ideas and technical approaches for the safe use of oncolytic viruses in the clinical treatment of canine tumors.

Key words: oncolytic virus; canine tumor; treatment

CLC Number:

R730.5

REN Xiaoli, FAN Yuying, JIN Shuangxing, ZHANG Lei, LIU Yun, SHI Dongmei. Research Progress on Oncolytic Viruses in Canine Tumor Treatment[J]. China Animal Husbandry and Veterinary Medicine, 2020, 47(3): 965-971.

References

[1] BAIONI E,SCANZIANI E,VINCENTI M C,et al.Estimating canine cancer incidence:Findings from a population-based tumour registry in northwestern Italy[J].BMC Veterinary Research,2017,13(1):203.
[2] ROMANO G,MARINO I R.Abscopal effects observed in cancer radiation therapy and oncolytic virotherapy:An overview[J].Drugs Today (Barc),2019,55(2):117-130.
[3] BLUMING A Z,ZIEGLER J L.Regression of Burkitt's lymphoma in association with measles infection[J].Lancet,1971,2(7715):105-106.
[4] BIERMAN H R,CRILE D M,DOD K S,et al.Remissions in leukemia of childhood following acute infectious disease:Staphylococcus and Streptococcus,varicella,and feline panleukopenia[J].Cancer,1953,6(3):591-605.
[5] HUEBNER R J,ROWE W P,SCHATTEN W E,et al.Studies on the use of viruses in the treatment of carcinoma of the cervix[J].Cancer,1956,9(6):1211-1218.
[6] SOUTHAM C M,MOORE A E.Clinical studies of viruses as antineoplastic agents with particular reference to Egypt 101 virus[J].Cancer,1952,5(5):1025-1034.
[7] GARBER K.China approves world's first oncolytic virus therapy for cancer treatment[J].Journal of the National Cancer Institute,2006,98(5):298-300.
[8] ELIE D.Oncolytic viruses get a boost with first FDA-approval recommendation[J].Nature Reviews Drug Discovery,2015,14(6)369-371.
[9] FU L Q,WANG S B,CAI M H,et al.Recent advances in oncolytic virus-based cancer therapy[J].Virus Research,2019,270:197675.
[10] BREITBACH C J,ARULANANDAM R,DE SILVA N,et al.Oncolytic vaccinia virus disrupts tumor-associated vasculature in humans[J].Cancer Research,2013,73(4):1265-1275.
[11] ADELFINGER M,BESSLER S,FRENTZEN A,et al.Preclinical testing oncolytic vaccinia virus strain GLV-5b451 expressing an anti-VEGF single-chain antibody for canine cancer therapy[J].Viruses,2015,7(7):4075-4092.
[12] LE BOEUF F,SELMAN M,SON H H,et al.Oncolytic maraba virus MG1 as a treatment for sarcoma[J].International Journal of Cancer,2017,141(6):1257-1264.
[13] BOMMAREDDY P K,SHETTIGAR M,KAUFMAN H L.Integrating oncolytic viruses in combination cancer immunotherapy[J].Nature Reviews Immunology,2018,18(8):498-513.
[14] MARCHINI A,DAEFFLER L,POZDEEV V I,et al.Immune conversion of tumor microenvironment by oncolytic viruses:The protoparvovirus H-1PV case study[J].Frontiers in Immunology,2019,10:1848.
[15] MELL L K,BRUMUND K T,DANIELS G A,et al.Phase Ⅰ trial of intravenous oncolytic vaccinia virus (GL-ONC1) with cisplatin and radiotherapy in patients with locoregionally advanced head and neck carcinoma[J].Clinical Cancer Research,2017,23(19):5696-5702.
[16] IGASE M,SHIBUTANI S,KUROGOUCHI Y,et al.Combination therapy with reovirus and ATM inhibitor enhances cell death and virus replication in canine melanoma[J].Molecular Therapy-Oncolytics,2019,15:49-59.
[17] HUANG H,LIU Y,LIAO W,et al.Oncolytic adenovirus programmed by synthetic gene circuit for cancer immunotherapy[J].Nature Communications,2019,10(1):4801.
[18] ZYGIERT Z.Hodgkin's disease:Remissions after measles[J].Lancet,1971,1(7699):593.
[19] TAQI A M,ABDURRAHMAN M B,YAKUBU A M,et al.Regression of Hodgkin's disease after measles[J].Lancet,1981,1(8229):1112.
[20] SINGH B K,HORNICK A L,KRISHNAMURTHY S,et al.The nectin-4/afadin protein complex and intercellular membrane pores contribute to rapid spread of measles virus in primary human airway epithelia[J].Journal of Virology,2015,89(14):7089-7096.
[21] DERYCKE M S,PAMBUCCIAN S E,GILKS C B,et al.Nectin 4 overexpression in ovarian cancer tissues and serum:Potential role as a serum biomarker[J].American Journal of Clinical Pathology,2010,134(5):835-845.
[22] SHOJI K,YONEDA M,FUJIYUKI T,et al.Development of new therapy for canine mammary cancer with recombinant measles virus[J].Molecular Therapy-Oncolytics,2016,3:15022.
[23] KHOSRAVI M,BRINGOLF F,ROTHLISBERGER S,et al.Canine distemper virus fusion activation:Critical role of residue E123 of CD150/SLAM[J].Journal of Virology,2016,90(3):1622-1637.
[24] DEL P H,MARTINS A S,MILSTED A,et al.Canine distemper virus induces apoptosis in cervical tumor derived cell lines[J].Virology Journal,2011,8:334.
[25] SUTER S E,CHEIN M B,VON MESSLING V,et al.In vitro canine distemper virus infection of canine lymphoid cells:A prelude to oncolytic therapy for lymphoma[J].Clinical Cancer Research,2005,11(4):1579-1587.
[26] GARCIA J A,FERREIRA H L,VIEIRA F V,et al.Tumour necrosis factor-alpha-induced protein 8(TNFAIP8) expression associated with cell survival and death in cancer cell lines infected with canine distemper virus[J].Veterinary and Comparative Oncology,2017,15(2):336-344.
[27] GRONE A,FONFARA S,BAUMGARTNER W.Cell type-dependent cytokine expression after canine distemper virus infection[J].Viral Immunology,2002,15(3):493-505.
[28] YAMAGUCHI R,KOJIMOTO A,SAKAI H,et al.Growth characteristics of canine distemper virus in a new cell line CCT cells originated from canine malignant histiocytosis[J].Journal of Veterinary Medical Science,2005,67(2):203-206.
[29] DERVISIS N G,KIUPEL M,QIN Q,et al.Clinical prognostic factors in canine histiocytic sarcoma[J].Veterinary and Comparative Oncology,2017,15(4):1171-1180.
[30] FORD R B,LARSON L J,MCCLURE K D,et al.2017 AAHA canine vaccination guidelines[J].Journal of the American Animal Hospital Association,2017,53(5):243-251.
[31] LI P,WANG J,CHEN G,et al.Oncolytic activity of canine distemper virus in canine mammary tubular adenocarcinoma cells[J].Veterinary and Comparative Oncology,2019,17(2):174-183.
[32] SANCHEZ D,PELAYO R,MEDINA L A,et al.Newcastle disease virus:Potential therapeutic application for human and canine lymphoma[J].Viruses,2015,8(1)E3.
[33] KOKS C A,GARG A D,EHRHARDT M,et al.Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death[J].International Journal of Cancer,2015,136(5):E313-E325.
[34] ILYINSKAYA G V,MUKHINA E V,SOBOLEVA A V,et al.Oncolytic Sendai virus therapy of canine mast cell tumors (a pilot study)[J].Frontiers in Veterinary Science,2018,5:116.
[35] DONNELLY L,MULLIN C,BALKO J,et al.Evaluation of histological grade and histologically tumour-free margins as predictors of local recurrence in completely excised canine mast cell tumours[J].Veterinary and Comparative Oncology,2015,13(1):70-76.
[36] NAIK S,GALYON G D,JENKS N J,et al.Comparative oncology evaluation of intravenous recombinant oncolytic vesicular stomatitis virus therapy in spontaneous canine cancer[J].Molecular Cancer Therapeutics,2018,17(1):316-326.
[37] LEBLANC A K,NAIK S,GALYON G D,et al.Safety studies on intravenous administration of oncolytic recombinant vesicular stomatitis virus in purpose-bred beagle dogs[J].Human Gene Therapy Clinical Development,2013,24(4):174-181.
[38] SHEN W,PATNAIK M M,RUIZ A,et al.Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia[J].Blood,2016,127(11):1449-1458.
[39] KIMPEL J,URBIOLA C,KOSKE I,et al.The oncolytic virus VSV-GP is effective against malignant melanoma[J].Viruses,2018,10(3):E108.
[40] HWANG C C,MOCHIZUKI M,MAEDA K,et al.Seroepidemiology of reovirus in healthy dogs in six prefectures in Japan[J].Journal of Veterinary Medical Science,2014,76(3):471-475.
[41] GONG J,SACHDEV E,MITA A C,et al.Clinical development of reovirus for cancer therapy:An oncolytic virus with immune-mediated antitumor activity[J].World Journal of Methodology,2016,6(1):25-42.
[42] HWANG C C,UMEKI S,IGASE M,et al.The effects of oncolytic reovirus in canine lymphoma cell lines[J].Veterinary and Comparative Oncology,2016,14(Suppl 1):61-73.
[43] IGASE M,SHOUSU K,FUJIKI N,et al.Anti-tumour activity of oncolytic reovirus against canine histiocytic sarcoma cells[J].Veterinary and Comparative Oncology,2019,17(2):184-193.
[44] NORMAN K L,HIRASAWA K,YANG A D,et al.Reovirus oncolysis:The Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection[J].Proceeding of the National of the United States of America,2004,101(30):11099-11104.
[45] IGASE M,HWANG C C,COFFEY M,et al.The oncolytic effects of reovirus in canine solid tumor cell lines[J].Journal of Veterinary Medical Science,2015,77(5):541-548.
[46] HWANG C C,IGASE M,SAKURAI M,et al.Oncolytic reovirus therapy:Pilot study in dogs with spontaneously occurring tumours[J].Veterinary and Comparative Oncology,2018,16(2):229-238.
[47] FREY S E,NEWMAN F K,CRUZ J,et al.Dose-related effects of smallpox vaccine[J].New England Journal of Medicine,2002,346(17):1275-1280.
[48] GENTSCHEV I,EHRIG K,DONAT U,et al.Significant growth inhibition of canine mammary carcinoma xenografts following treatment with oncolytic vaccinia virus GLV-1h68[J].Journal of Oncology,2010,2010:736907.
[49] GENTSCHEV I,ADELFINGER M,JOSUPEIT R,et al.Preclinical evaluation of oncolytic vaccinia virus for therapy of canine soft tissue sarcoma[J].PLoS One,2012,7(5):e37239.
[50] PATIL S S,GENTSCHEV I,ADELFINGER M,et al.Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody[J].PLoS One,2012,7(10):e47472.
[51] GENTSCHEV I,PATIL S S,ADELFINGER M,et al.Characterization and evaluation of a new oncolytic vaccinia virus strain LIVP6.1.1 for canine cancer therapy[J].Bioengineered,2013,4(2):84-89.
[52] ALCAYAGA-MIRANDA F,CASCALLO M,ROJAS J J,et al.Osteosarcoma cells as carriers to allow antitumor activity of canine oncolytic adenovirus in the presence of neutralizing antibodies[J].Cancer Gene Therapy,2010,17(11):792-802.
[53] LABORDA E,PUIG-SAUS C,RODRIGUEZ-GARCIA A,et al.A pRb-responsive,RGD-modified,and hyaluronidase-armed canine oncolytic adenovirus for application in veterinary oncology[J].Molecular Therapy,2014,22(5):986-998.
[54] CEJALVO T,PERISE-BARRIOS A J,DEL P I,et al.Remission of spontaneous canine tumors after systemic cellular viroimmunotherapy[J].Cancer Research,2018,78(17):4891-4901.
[55] TERNOVOI V V,LE L P,BELOUSOVA N,et al.Productive replication of human adenovirus type 5 in canine cells[J].Journal of Virology,2005,79(2):1308-1311.
[56] WESTBERG S,SADEGHI A,SVENSSON E,et al.Treatment efficacy and immune stimulation by AdCD40L gene therapy of spontaneous canine malignant melanoma[J].Journal of Immunotherapy,2013,36(6):350-358.

Research Progress on Oncolytic Viruses in Canine Tumor Treatment

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	YANG Zhi, YU Jiaxin, YANG Linfu, WANG Kang, LI Guanzong, DUAN Gang, YANG Fumei, LIU Zhiqi, ZHOU Ke, HE Jun, DAI Feiyan. Study on the Therapeutic Effect of Modified Sini Decoction on Piglet Diarrhea [J]. China Animal Husbandry and Veterinary Medicine, 2023, 50(4): 1707-1717.
[2]	LI Min, ZHAO Zunfu, YANG Tingting, ZHANG Huanrong. Prevention and Treatment Effect of Escherichia coli Phage BP16 on Chicken Colibacillosis [J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(2): 776-782.
[3]	JIAO Ying, JI Lingxi, HUANG Wei, XIAO Meng, LYU Yanli. Diagnosis and Treatment of Feline Dermatophytic Pseudomycetoma [J]. China Animal Husbandry and Veterinary Medicine, 2021, 48(3): 1141-1147.
[4]	WANG Antian, HUANG Jing, SUN Yufan, SONG Bingxiao, TAN Chen, HUANG Qi, ZHOU Rui, LI Lu. Antibacterial Activity of Porcine Beta Defensin-2 Against Porcine Extraintestinal Pathogenic Escherichia coli in vivo and in vitro [J]. China Animal Husbandry and Veterinary Medicine, 2021, 48(2): 726-735.
[5]	XU Xi, YANG Sha, HAO Haisheng, DU Weihua, PANG Yunwei, ZHAO Shanjiang, ZOU Huiying, ZHU Huabin, LI Shujing, YU Wenli, ZHAO Xueming. Research Progress on Application of Single Base Editing Technology [J]. China Animal Husbandry and Veterinary Medicine, 2021, 48(12): 4403-4411.
[6]	BAI Weiqin, LI Hong, MENG Ke, ZI Zhanfei, LI Jie, ZHAO Lijun, WANG Jinling, GE Riletu, LI Qi, JI Lintai. Isolation and Identification of a Pathogenic Enterococcus faecium from Sheep [J]. China Animal Husbandry and Veterinary Medicine, 2021, 48(10): 3889-3895.
[7]	ZHENG Jian, YANG Jinshan, FANG Xinpeng, ZHAO Hongbo, ZHANG Yonggen. The Optimization of Ultrasonic to Improve the Fiber Structure of Ammoniated Rice Straw and Its Effect on Rumen Degradation Characteristics [J]. China Animal Husbandry and Veterinary Medicine, 2020, 47(7): 2033-2042.
[8]	TAN Shumin, ZHOU Jizhang. Research Progress on Vaccine Immunization and Treatment of Animal Chlamydiosis [J]. China Animal Husbandry and Veterinary Medicine, 2020, 47(5): 1539-1546.
[9]	QIN Feng, LIU Yun, WU Zhi, FENG Qi, WU Shuang, SONG Haigang, WU Xiaojie, ZHU Shanyuan. Study on the Prevention and Control Effect of Chinese Herbal Compound on E.coli Infected Ducklings [J]. China Animal Husbandry and Veterinary Medicine, 2020, 47(10): 3371-3378.
[10]	HE Xiangbo, LI Ying, XU Jincong, MIAO Jing, GAN Qianfu, LIANG Xuewu. Effect of Alkali Storage Treatments on Ruminal Nutrients Degradability of Spent Mushroom Substrate [J]. , 2019, 46(5): 1340-1352.
[11]	WANG Yuke, OU Yahong, ZHANG Liyun, WANG Yanxin, WANG Xu, PENG Dapeng, WANG Yulian, PAN Yuanhu, XIE Shuyu, CHEN Dongmei, HUANG Lingli, TAO Yanfei. Research Progress on Sample Preparation for Detection of Sulfonamides and Its Metabolites in Animal Food and Environment [J]. China Animal Husbandry and Veterinary Medicine, 2019, 46(10): 3032-3041.
[12]	XU Hongjian, ZHANG Liyang, LIU Xin, JIANG Xin, LI Xin, ZHANG Yonggen. Study on the Correlation Between the CNCPS Fractions and Furosine Content in DDGS with Different Heat Treatment [J]. , 2018, 45(12): 3471-3478.
[13]	ZHENG Xinxin, LI Fukuan, PAN Zhangyuan, LV Shenjin, WANG Hui. Research Progress on Pharmacological Action of Astragalus Polysaccharide and Its Application in Piglet Disease Prevention and Treatment [J]. , 2018, 45(10): 2918-2926.
[14]	YANG Xia, ZHANG Dian-qing, SONG Jia-wei, XIAO Sheng-zhong, SHENG Jin-liang, YAN Gen-qiang. Antimicrobial Activity of Synthesized Sheep NK-Lysin Peptides and Its Treatment for Chicken Salmonella Challenge [J]. , 2017, 44(9): 2739-2746.
[15]	ZHANG Jing-wei, XU Lu-yao, HU Chang-min. Research Progress on Diagnosis and Treatment of Canine and Feline Dermatophytosis [J]. , 2017, 44(9): 2801-2808.